Spyre Therapeutics
SYRE
SYRE
70 hedge funds and large institutions have $95.8M invested in Spyre Therapeutics in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 23 increasing their positions, 22 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
70
Holders Change
+2
Holders Change %
+2.94%
% of All Funds
1.55%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
9
Increased
23
Reduced
22
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AG
Artal Group
Luxembourg
|
+$466K |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$365K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$186K |
| 4 |
D.E. Shaw & Co
New York
|
+$127K |
| 5 |
Renaissance Technologies
New York
|
+$111K |
